{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:27:20Z","timestamp":1786116440115,"version":"build-2736575974"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health","award":["RO1, HL149730"],"award-info":[{"award-number":["RO1, HL149730"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"DOI":"10.1007\/s11883-026-01445-9","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:14:58Z","timestamp":1786004098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sphingolipids and Atherosclerosis"],"prefix":"10.1007","volume":"28","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2030-9542","authenticated-orcid":false,"given":"Xian-Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1445_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","volume":"15","author":"KJ Williams","year":"1995","unstructured":"Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nature00804","volume":"417","author":"K Sk\u00e5l\u00e9n","year":"2002","unstructured":"Sk\u00e5l\u00e9n K, Gustafsson M, Rydberg EK, Hult\u00e9n LM, Wiklund O, Innerarity TL, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750\u20134.","journal-title":"Nature"},{"key":"1445_CR3","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","volume":"116","author":"I Tabas","year":"2007","unstructured":"Tabas I, Williams KJ, Bor\u00e9n J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007;116:1832\u201344.","journal-title":"Circulation"},{"key":"1445_CR4","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","volume":"27","author":"E Galkina","year":"2007","unstructured":"Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2292\u2013301.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","volume":"4","author":"SO Rahaman","year":"2006","unstructured":"Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006;4:211\u201321.","journal-title":"Cell Metab"},{"key":"1445_CR6","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1172\/JCI24061","volume":"115","author":"KJ Moore","year":"2005","unstructured":"Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, Freeman MW. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest. 2005;115:2192\u2013201.","journal-title":"J Clin Invest"},{"key":"1445_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U F\u00f6rstermann","year":"2017","unstructured":"F\u00f6rstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120:713\u201335.","journal-title":"Circ Res"},{"key":"1445_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","volume":"100","author":"MA Incalza","year":"2018","unstructured":"Incalza MA, D\u2019Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1\u201319.","journal-title":"Vascul Pharmacol"},{"key":"1445_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1006\/taap.1996.8029","volume":"142","author":"AH Merrill","year":"1997","unstructured":"Merrill AH, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E. Sphingolipids\u2013the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997;142:208\u201325.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1445_CR10","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","volume":"36","author":"A Edsfeldt","year":"2016","unstructured":"Edsfeldt A, Dun\u00e9r P, St\u00e5hlman M, Mollet IG, Asciutto G, Grufman H, Nitulescu M, Persson AF, Fisher RM, Melander O, Orho-Melander M, Bor\u00e9n J, Nilsson J, Gon\u00e7alves I. Arterioscler Thromb Vasc Biol. 2016;36:1132\u201340. Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","volume":"71","author":"AS Plump","year":"1992","unstructured":"Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343\u201353.","journal-title":"Cell"},{"key":"1445_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI870","volume":"101","author":"T Jeong","year":"1998","unstructured":"Jeong T, Schissel SL, Tabas I, Pownall HJ, Tall AR, Jiang X. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest. 1998;101:905\u201312.","journal-title":"J Clin Invest"},{"key":"1445_CR13","doi-asserted-by":"publisher","first-page":"10284","DOI":"10.1074\/jbc.M412348200","volume":"280","author":"MR Hojjati","year":"2005","unstructured":"Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S, Jiang XC. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem. 2005;280:10284\u20139.","journal-title":"J Biol Chem"},{"key":"1445_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1194\/jlr.M700261-JLR200","volume":"49","author":"EN Glaros","year":"2008","unstructured":"Glaros EN, Kim WS, Quinn CM, Jessup W, Rye KA, Garner B. Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice. J Lipid Res. 2008;49:324\u201331.","journal-title":"J Lipid Res"},{"key":"1445_CR15","doi-asserted-by":"publisher","first-page":"e0126910","DOI":"10.1371\/journal.pone.0126910","volume":"10","author":"T Kasumov","year":"2015","unstructured":"Kasumov T, Li L, Li M, Gulshan K, Kirwan JP, Liu X, Previs S, Willard B, Smith JD, McCullough A. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis. PLoS ONE. 2015;10:e0126910.","journal-title":"PLoS ONE"},{"key":"1445_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.phrs.2008.06.005","volume":"58","author":"TS Park","year":"2008","unstructured":"Park TS, Rosebury W, Kindt EK, Kowala MC, Panek RL. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. Pharmacol Res. 2008;58:45\u201351.","journal-title":"Pharmacol Res"},{"key":"1445_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1445_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.emboj.7600034","volume":"23","author":"K Huitema","year":"2004","unstructured":"Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC. Identification of a family of animal sphingomyelin synthases. EMBO J. 2004;23:33\u201344.","journal-title":"EMBO J"},{"key":"1445_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2025.100908","author":"X Li","year":"2025","unstructured":"Li X, Li Z, Chiang YP, Worgall T, Souaiaia T, Jiang XC. Sphingomyelin synthase related protein is a regulator of serine palmitoyltransferase. J Lipid Res. 2025. https:\/\/doi.org\/10.1016\/j.jlr.2025.100908.","journal-title":"J Lipid Res"},{"key":"1445_CR20","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1074\/jbc.M401205200","volume":"279","author":"S Yamaoka","year":"2004","unstructured":"Yamaoka S, Miyaji M, Kitano T, Umehara H, Okazaki T. Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J Biol Chem. 2004;279:18688\u201393.","journal-title":"J Biol Chem"},{"key":"1445_CR21","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1073\/pnas.1602875113","volume":"113","author":"Y Deng","year":"2016","unstructured":"Deng Y, Rivera-Molina FE, Toomre DK, Burd CG. Sphingomyelin is sorted at the trans Golgi network into a distinct class of secretory vesicle. Proc Natl Acad Sci U S A. 2016;113:6677\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1445_CR22","doi-asserted-by":"publisher","first-page":"25855","DOI":"10.1074\/jbc.R200010200","volume":"277","author":"G van Meer","year":"2002","unstructured":"van Meer G, Lisman Q. Sphingolipid transport: rafts and translocators. J Biol Chem. 2002;277:25855\u20138.","journal-title":"J Biol Chem"},{"key":"1445_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","volume":"1488","author":"T Hevonoja","year":"2000","unstructured":"Hevonoja T, Pentik\u00e4inen MO, Hyv\u00f6nen MT, Kovanen PT, Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim Biophys Acta. 2000;1488:189\u2013210.","journal-title":"Biochim Biophys Acta"},{"key":"1445_CR24","doi-asserted-by":"publisher","first-page":"105162","DOI":"10.1016\/j.jbc.2023.105162","volume":"299","author":"YP Chiang","year":"2023","unstructured":"Chiang YP, Li Z, He M, Jones Q, Pan M, Han X, Jiang XC. Sphingomyelin synthase-related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease. J Biol Chem. 2023;299:105162.","journal-title":"J Biol Chem"},{"key":"1445_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-981-19-0394-6_7","volume":"1372","author":"XC Jiang","year":"2022","unstructured":"Jiang XC, Chiang YP. Sphingomyelin Synthase Family and Phospholipase Cs. Adv Exp Med Biol. 2022;1372:77\u201386.","journal-title":"Adv Exp Med Biol"},{"key":"1445_CR26","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1111\/febs.12559","volume":"280","author":"G D\u2019Angelo","year":"2013","unstructured":"D\u2019Angelo G, Capasso S, Sticco L, Russo D. Glycosphingolipids: synthesis and functions. FEBS J. 2013;280:6338\u201353.","journal-title":"FEBS J"},{"key":"1445_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbagen.2007.10.008","volume":"1780","author":"A Regina Todeschini","year":"2008","unstructured":"Regina Todeschini A, Hakomori SI. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 2008;1780:421\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"1445_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fimmu.2019.00090","volume":"10","author":"T Zhang","year":"2019","unstructured":"Zhang T, de Waard AA, Wuhrer M, Spaapen RM. The Role of Glycosphingolipids in Immune Cell Functions. Front Immunol. 2019;10:90.","journal-title":"Front Immunol"},{"key":"1445_CR29","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1002\/1873-3468.13275","volume":"592","author":"H Nakayama","year":"2018","unstructured":"Nakayama H, Nagafuku M, Suzuki A, Iwabuchi K, Inokuchi JI. The regulatory roles of glycosphingolipid-enriched lipid rafts in immune systems. FEBS Lett. 2018;592:3921\u201342.","journal-title":"FEBS Lett"},{"key":"1445_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012;22:50\u201360.","journal-title":"Trends Cell Biol"},{"key":"1445_CR31","doi-asserted-by":"publisher","first-page":"4806541","DOI":"10.1155\/2017\/4806541","volume":"2017","author":"NC Hait","year":"2017","unstructured":"Hait NC, Maiti A. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer. Mediators Inflamm. 2017;2017:4806541.","journal-title":"Mediators Inflamm"},{"key":"1445_CR32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/381800a0","volume":"381","author":"O Cuvillier","year":"1996","unstructured":"Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996;381:800\u20133.","journal-title":"Nature"},{"key":"1445_CR33","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1096\/fasebj.10.12.8903509","volume":"10","author":"S Spiegel","year":"1996","unstructured":"Spiegel S, Merrill AH. Sphingolipid metabolism and cell growth regulation. FASEB J. 1996;10:1388\u201397.","journal-title":"FASEB J"},{"key":"1445_CR34","doi-asserted-by":"publisher","first-page":"37275","DOI":"10.1074\/jbc.M608066200","volume":"281","author":"T Hornemann","year":"2006","unstructured":"Hornemann T, Richard S, Rutti MF, Wei Y, von Eckardstein A. Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase. J Biol Chem. 2006;281:37275\u201381.","journal-title":"J Biol Chem"},{"key":"1445_CR35","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1073\/pnas.0811269106","volume":"106","author":"G Han","year":"2009","unstructured":"Han G, Gupta SD, Gable K, Niranjanakumari S, Moitra P, Eichler F, Brown RH Jr., Harmon JM, Dunn TM. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci USA. 2009;106:8186\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1445_CR36","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/nature08787","volume":"463","author":"DK Breslow","year":"2010","unstructured":"Breslow DK, Collins SR, Bodenmiller B, Aebersold R, Simons K, Shevchenko A, Ejsing CS, Weissman JS. Orm family proteins mediate sphingolipid homeostasis. Nature. 2010;463:1048\u201353.","journal-title":"Nature"},{"key":"1445_CR37","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1073\/pnas.0911617107","volume":"107","author":"S Han","year":"2010","unstructured":"Han S, Lone MA, Schneiter R, Chang A. Orm1 and Orm2 are conserved endoplasmic reticulum membrane proteins regulating lipid homeostasis and protein quality control. Proc Natl Acad Sci U S A. 2010;107:5851\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1445_CR38","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1194\/jlr.M057539","volume":"56","author":"D Siow","year":"2015","unstructured":"Siow D, Sunkara M, Dunn TM, Morris AJ, Wattenberg B. ORMDL\/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on sphingolipid biosynthesis. J Lipid Res. 2015;56:898\u2013908.","journal-title":"J Lipid Res"},{"key":"1445_CR39","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1074\/jbc.M114.595116","volume":"290","author":"K Kiefer","year":"2015","unstructured":"Kiefer K, Carreras-Sureda A, Garcia-Lopez R, Rubio-Moscardo F, Casas J, Fabrias G, Vicente R. Coordinated regulation of the orosomucoid-like gene family expression controls de novo ceramide synthesis in mammalian cells. J Biol Chem. 2015;290:2822\u201330.","journal-title":"J Biol Chem"},{"key":"1445_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41594-020-00553-7","volume":"28","author":"S Li","year":"2021","unstructured":"Li S, Xie T, Liu P, Wang L, Gong X. Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex. Nat Struct Mol Biol. 2021;28:249\u201357.","journal-title":"Nat Struct Mol Biol"},{"key":"1445_CR41","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1074\/jbc.M209602200","volume":"278","author":"S Yasuda","year":"2003","unstructured":"Yasuda S, Nishijima M, Hanada K. Localization, topology, and function of the LCB1 subunit of serine palmitoyltransferase in mammalian cells. J Biol Chem. 2003;278:4176\u201383.","journal-title":"J Biol Chem"},{"key":"1445_CR42","doi-asserted-by":"publisher","first-page":"26322","DOI":"10.1074\/jbc.M109.023192","volume":"284","author":"T Hornemann","year":"2009","unstructured":"Hornemann T, Penno A, Rutti MF, Ernst D, Kivrak-Pfiffner F, Rohrer L, von Eckardstein A. The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J Biol Chem. 2009;284:26322\u201330.","journal-title":"J Biol Chem"},{"key":"1445_CR43","doi-asserted-by":"crossref","unstructured":"Kovilakath A, Mauro AG, Valentine Y, Raucci F, Jamil M, Carter C, Thompson J, Chen Q, Gisela B, Yue Y, Allegood J, Wang XX, Dail J, Devarakonda T, Myakala K, Windle JJ, Subler MA, Montefusco D, Willard B, Javaheri A, Bernas T, Mahata SK, Levi M, Liu J, Porter GA Jr., Lesnefsky EJ, Salloum FN, Cowart LA. SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy, Circulation, (2024).","DOI":"10.1161\/CIRCULATIONAHA.123.066879"},{"key":"1445_CR44","unstructured":"C.J. Willer, E.M. Schmidt, S. Sengupta, G.M. Peloso, S. Gustafsson, S. Kanoni, A.Ganna, J. Chen, M.L. Buchkovich, S. Mora, J.S. Beckmann, J.L. Bragg-Gresham, H.Y.Chang, A. Demirkan, H.M. Den Hertog, R. Do, L.A. Donnelly, G.B. Ehret, T. Esko, M.F.Feitosa, T. Ferreira, K. Fischer, P. Fontanillas, R.M. Fraser, D.F. Freitag, D. Gurdasani,K. Heikkila, E. Hypponen, A. Isaacs, A.U. Jackson, A. Johansson, T. Johnson, M. Kaakinen,J. Kettunen, M.E. Kleber, X. Li, J. Luan, L.P. Lyytikainen, P.K.E. Magnusson, M. Mangino,E. Mihailov, M.E. Montasser, M. Muller-Nurasyid, I.M. Nolte, J.R. O\u2019Connell, C.D.Palmer, M. Perola, A.K. Petersen, S. Sanna, R. Saxena, S.K. Service, S. Shah, D. Shungin,C. Sidore, C. Song, R.J. Strawbridge, I. Surakka, T. Tanaka, T.M. Teslovich, G. Thorleifsson,E.G. Van den Herik, B.F. Voight, K.A. Volcik, L.L. Waite, A. Wong, Y. Wu, W. Zhang,D. Absher, G. Asiki, I. Barroso, L.F. Been, J.L. Bolton, L.L. Bonnycastle, P. Brambilla,M.S. Burnett, G. Cesana, M. Dimitriou, A.S.F. Doney, A. Doring, P. Elliott, S.E. Epstein,G. Ingi Eyjolfsson, B. Gigante, M.O. Goodarzi, H. Grallert, M.L. Gravito, C.J. Groves,G. Hallmans, A.L. Hartikainen, C. Hayward, D. Hernandez, A.A. Hicks, H. Holm, Y.J.Hung, T. Illig, M.R. Jones, P. Kaleebu, J.J.P. Kastelein, K.T. Khaw, E. Kim, N. Klopp,P. Komulainen, M. Kumari, C. Langenberg, T. Lehtimaki, S.Y. Lin, J. Lindstrom, R.J.F.Loos, F. Mach, W.L. McArdle, C. Meisinger, B.D. Mitchell, G. Muller, R. Nagaraja,N. Narisu, T.V.M. Nieminen, R.N. Nsubuga, I. Olafsson, K.K. Ong, A. Palotie, T. Papamarkou,C. Pomilla, A. Pouta, D.J. Rader, M.P. Reilly, P.M. Ridker, F. Rivadeneira, I. Rudan,A. Ruokonen, N. Samani, H. Scharnagl, J. Seeley, K. Silander, A. Stancakova, K. Stirrups,A.J. Swift, L. Tiret, A.G. Uitterlinden, L.J. van Pelt, S. Vedantam, N. Wainwright,C. Wijmenga, S.H. Wild, G. Willemsen, T. Wilsgaard, J.F. Wilson, E.H. Young, J.H.Zhao, L.S. Adair, D. Arveiler, T.L. Assimes, S. Bandinelli, F. Bennett, M. Bochud,B.O. Boehm, D.I. Boomsma, I.B. Borecki, S.R. Bornstein, P. Bovet, M. Burnier, H. Campbell,A. Chakravarti, J.C. Chambers, Y.I. Chen, F.S. Collins, R.S. Cooper, J. Danesh, G.Dedoussis, U. de Faire, A.B. Feranil, J. Ferrieres, L. Ferrucci, N.B. Freimer, C.Gieger, L.C. Groop, V. Gudnason, U. Gyllensten, A. Hamsten, T.B. Harris, A. Hingorani,J.N. Hirschhorn, A. Hofman, G.K. Hovingh, C.A. Hsiung, S.E. Humphries, S.C. Hunt,K. Hveem, C. Iribarren, M.R. Jarvelin, A. Jula, M. Kahonen, J. Kaprio, A. Kesaniemi,M. Kivimaki, J.S. Kooner, P.J. Koudstaal, R.M. Krauss, D. Kuh, J. Kuusisto, K.O. Kyvik,M. Laakso, T.A. Lakka, L. Lind, C.M. Lindgren, N.G. Martin, W. Marz, M.I. McCarthy,C.A. McKenzie, P. Meneton, A. Metspalu, L. Moilanen, A.D. Morris, P.B. Munroe, I.Njolstad, N.L. Pedersen, C. Power, P.P. Pramstaller, J.F. Price, B.M. Psaty, T. Quertermous,R. Rauramaa, D. Saleheen, V. Salomaa, D.K. Sanghera, J. Saramies, P.E.H. Schwarz,W.H. Sheu, A.R. Shuldiner, A. Siegbahn, T.D. Spector, K. Stefansson, D.P. Strachan,B.O. Tayo, E. Tremoli, J. Tuomilehto, M. Uusitupa, C.M. van Duijn, P. Vollenweider,L. Wallentin, N.J. Wareham, J.B. Whitfield, B.H.R. Wolffenbuttel, J.M. Ordovas, E.Boerwinkle, C.N.A. Palmer, U. Thorsteinsdottir, D.I. Chasman, J.I. Rotter, P.W. Franks,S. Ripatti, L.A. Cupples, M.S. Sandhu, S.S. Rich, M. Boehnke, P. Deloukas, S. Kathiresan,K.L. Mohlke, E. Ingelsson, G.R. Abecasis, C. Global Lipids Genetics, Discovery and refinement of loci associated with lipid levels, Nat Genet, 45 (2013) 1274\u20131283."},{"key":"1445_CR45","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1038\/s41467-019-11954-8","volume":"10","author":"R Tabassum","year":"2019","unstructured":"Tabassum R, Ramo JT, Ripatti P, Koskela JT, Kurki M, Karjalainen J, Palta P, Hassan S, Nunez-Fontarnau J, Kiiskinen TTJ, Soderlund S, Matikainen N, Gerl MJ, Surma MA, Klose C, Stitziel NO, Laivuori H, Havulinna AS, Service SK, Salomaa V, Pirinen M, FinnGen P, Jauhiainen M, Daly MJ, Freimer NB, Palotie A, Taskinen MR, Simons K, Ripatti S. Genetic architecture of human plasma lipidome and its link to cardiovascular disease. Nat Commun. 2019;10:4329.","journal-title":"Nat Commun"},{"key":"1445_CR46","doi-asserted-by":"publisher","first-page":"172","DOI":"10.12997\/jla.2020.9.1.172","volume":"9","author":"S Cresci","year":"2020","unstructured":"Cresci S, Zhang R, Yang Q, Duncan MS, Xanthakis V, Jiang X, Vasan RS, Schaffer JE, Peterson LR. Genetic Architecture of Circulating Very-Long-Chain (C24:0 and C22:0) Ceramide Concentrations. J Lipid Atheroscler. 2020;9:172\u201383.","journal-title":"J Lipid Atheroscler"},{"key":"1445_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/hmg\/ddab002","volume":"30","author":"KA McGurk","year":"2021","unstructured":"McGurk KA, Williams SG, Guo H, Watkins H, Farrall M, Cordell HJ, et al. Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome. Hum Mol Genet. 2021;30:500\u201313.","journal-title":"Hum Mol Genet"},{"key":"1445_CR48","doi-asserted-by":"publisher","first-page":"9128","DOI":"10.1074\/jbc.M111.302380","volume":"287","author":"N Hagen-Euteneuer","year":"2012","unstructured":"Hagen-Euteneuer N, Lutjohann D, Park H, Merrill AH Jr., van Echten-Deckert G. Sphingosine 1-phosphate (S1P) lyase deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons. J Biol Chem. 2012;287:9128\u201336.","journal-title":"J Biol Chem"},{"key":"1445_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2025.100908","volume":"66","author":"X Li","year":"2025","unstructured":"Li X, Li Z, Chiang YP, Worgall T, Souaiaia T, Jiang XC. Sphingomyelin synthase-related protein is a regulator of serine palmitoyltransferase. J Lipid Res. 2025;66:100908.","journal-title":"J Lipid Res"},{"key":"1445_CR50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41594-024-01237-2","volume":"31","author":"K Hu","year":"2024","unstructured":"Hu K, Zhang Q, Chen Y, Yang J, Xia Y, Rao B, Li S, Shen Y, Cao M, Lu H, Qin A, Jiang XC, Yao D, Zhao J, Zhou L, Cao Y. Cryo-EM structure of human sphingomyelin synthase and its mechanistic implications for sphingomyelin synthesis. Nat Struct Mol Biol. 2024;31:884\u201395.","journal-title":"Nat Struct Mol Biol"},{"key":"1445_CR51","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, Suoniemi M, Hurme R, M\u00e4rz W, Scharnagl H, Stojakovic T, Vlachopoulou E, Lokki ML, Nieminen MS, Klingenberg R, Matter CM, Hornemann T, J\u00fcni P, Rodondi N, R\u00e4ber L, Windecker S, Gencer B, Pedersen ER, Tell GS, Nyg\u00e5rd O, Mach F, Sinisalo J, L\u00fcscher TF. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. 2016;37:1967\u201376.","journal-title":"Eur Heart J"},{"key":"1445_CR52","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1161\/ATVBAHA.120.315530","volume":"41","author":"VC Vasile","year":"2021","unstructured":"Vasile VC, Meeusen JW, Medina Inojosa JR, Donato LJ, Scott CG, Hyun MS, et al. Ceramide scores predict cardiovascular risk in the community. Arterioscler Thromb Vasc Biol. 2021;41:1558\u201369.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR53","doi-asserted-by":"publisher","first-page":"e015258","DOI":"10.1161\/JAHA.119.015258","volume":"9","author":"M Hilvo","year":"2020","unstructured":"Hilvo M, Wallentin L, Ghukasyan Lakic T, Held C, Kauhanen D, Jylh\u00e4 A, Lindb\u00e4ck J, Siegbahn A, Granger CB, Koenig W, Stewart RAH, White H, Laaksonen R, Investigators S. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy. J Am Heart Assoc. 2020;9:e015258.","journal-title":"J Am Heart Assoc"},{"key":"1445_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12265-020-09978-3","volume":"14","author":"W Pan","year":"2021","unstructured":"Pan W, Dong H, Sun R, Zhao L, Sun M, Li L, Yu X, Liu J, Wu J, Yang F, Yu B. Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography. J Cardiovasc Transl Res. 2021;14:140\u20139.","journal-title":"J Cardiovasc Transl Res"},{"key":"1445_CR55","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI118934","volume":"98","author":"SL Schissel","year":"1996","unstructured":"Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest. 1996;98:1455\u201364.","journal-title":"J Clin Invest"},{"key":"1445_CR56","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1161\/01.ATV.0000168912.42941.60","volume":"25","author":"K O\u00f6rni","year":"2005","unstructured":"O\u00f6rni K, Posio P, Ala-Korpela M, Jauhiainen M, Kovanen PT. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans. Arterioscler Thromb Vasc Biol. 2005;25:1678\u201383.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR57","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12944-025-02706-3","volume":"24","author":"J Ren","year":"2025","unstructured":"Ren J, Wang G, Wang Y, Li L, Sun J, Liu S, Wu X, Zhang C, Ruan L. Increased plasma ceramide levels are associated with arterial stiffness and vascular ageing: a cross-sectional study. Lipids Health Dis. 2025;24:272.","journal-title":"Lipids Health Dis"},{"key":"1445_CR58","doi-asserted-by":"publisher","first-page":"23283","DOI":"10.3390\/ijms151223283","volume":"15","author":"LA Bojic","year":"2014","unstructured":"Bojic LA, McLaren DG, Shah V, Previs SF, Johns DG, Castro-Perez JM. Lipidome of atherosclerotic plaques from hypercholesterolemic rabbits. Int J Mol Sci. 2014;15:23283\u201393.","journal-title":"Int J Mol Sci"},{"key":"1445_CR59","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","volume":"20","author":"XC Jiang","year":"2000","unstructured":"Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin M, et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 2000;20:2614\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR60","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/ATVBAHA.109.199281","volume":"30","author":"J Yeboah","year":"2010","unstructured":"Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, Burke GL, Shea S. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:628\u201333.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR61","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708","volume":"12","author":"RN Lemaitre","year":"2019","unstructured":"Lemaitre RN, Jensen PN, Hoofnagle A, McKnight B, Fretts AM, King IB, et al. Plasma ceramides and sphingomyelins in relation to heart failure risk. Circ Heart Fail. 2019;12:e005708.","journal-title":"Circ Heart Fail"},{"key":"1445_CR62","doi-asserted-by":"publisher","first-page":"e2343854","DOI":"10.1001\/jamanetworkopen.2023.43854","volume":"6","author":"LB Bockus","year":"2023","unstructured":"Bockus LB, Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Sitlani CM, Siscovick DS, King IB, Psaty BM, Sotoodehnia N, Lemaitre RN. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study. JAMA Netw Open. 2023;6:e2343854.","journal-title":"JAMA Netw Open"},{"key":"1445_CR63","doi-asserted-by":"publisher","first-page":"e032536","DOI":"10.1161\/JAHA.123.032536","volume":"13","author":"AM Fretts","year":"2024","unstructured":"Fretts AM, Jensen PN, Sitlani CM, Hoofnagle A, Lidgard B, Umans JG, Siscovick DS, King IB, Howard BV, Cole SA, Lemaitre RN. Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study. J Am Heart Assoc. 2024;13:e032536.","journal-title":"J Am Heart Assoc"},{"key":"1445_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01596-4","volume":"21","author":"PN Jensen","year":"2022","unstructured":"Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Howard BV, Umans JG, et al. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. Cardiovasc Diabetol. 2022;21:167.","journal-title":"Cardiovasc Diabetol"},{"key":"1445_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15043-y","volume":"7","author":"PM Christensen","year":"2017","unstructured":"Christensen PM, Bosteen MH, Hajny S, Nielsen LB, Christoffersen C. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes. Sci Rep. 2017;7:14983.","journal-title":"Sci Rep"},{"key":"1445_CR66","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00395-010-0112-5","volume":"105","author":"KJ Sattler","year":"2010","unstructured":"Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Gr\u00e4ler MH, Br\u00f6cker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol. 2010;105:821\u201332.","journal-title":"Basic Res Cardiol"},{"key":"1445_CR67","doi-asserted-by":"publisher","first-page":"e0168302","DOI":"10.1371\/journal.pone.0168302","volume":"11","author":"I Soltau","year":"2016","unstructured":"Soltau I, Mudersbach E, Geissen M, Schwedhelm E, Winkler MS, Geffken M, Peine S, Schoen G, Debus ES, Larena-Avellaneda A, Daum G. Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans. PLoS ONE. 2016;11:e0168302.","journal-title":"PLoS ONE"},{"key":"1445_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1432-1033.1989.tb14628.x","volume":"180","author":"NV Prokazova","year":"1989","unstructured":"Prokazova NV, Mukhin DN, Orekhov AN, Gladkaya EM, Vasilevskaya VV, Mikhailenko IA, et al. Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue. Eur J Biochem. 1989;180:167\u201371.","journal-title":"Eur J Biochem"},{"key":"1445_CR69","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1161\/01.ATV.15.10.1607","volume":"15","author":"DN Mukhin","year":"1995","unstructured":"Mukhin DN, Chao FF, Kruth HS. Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1607\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR70","doi-asserted-by":"crossref","unstructured":"Slijkhuis N, Razzi F, Korteland SA, Heijs B, van Gaalen K, Duncker DJ, et al. Spatial lipidomics of coronary atherosclerotic plaque development in a familial hypercholesterolemia swine model. J Lipid Res. 2024;65:100504.","DOI":"10.1016\/j.jlr.2024.100504"},{"key":"1445_CR71","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2337\/db11-1399","volume":"61","author":"QJ Zhang","year":"2012","unstructured":"Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, Kowalski CA, Deeter N, Nichols A, Deesing M, Arrant C, Ruan T, Boehme C, McCamey DR, Rou J, Ambal K, Narra KK, Summers SA, Abel ED, Symons JD. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes. 2012;61:1848\u201359.","journal-title":"Diabetes"},{"key":"1445_CR72","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.2337\/db15-0244","volume":"64","author":"LP Bharath","year":"2015","unstructured":"Bharath LP, Ruan T, Li Y, Ravindran A, Wan X, Nhan JK, et al. Ceramide-initiated protein phosphatase 2A activation contributes to arterial dysfunction in vivo. Diabetes. 2015;64:3914\u201326.","journal-title":"Diabetes"},{"key":"1445_CR73","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/CIRCRESAHA.115.303881","volume":"115","author":"JK Freed","year":"2014","unstructured":"Freed JK, Beyer AM, LoGiudice JA, Hockenberry JC, Gutterman DD. Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation. Circ Res. 2014;115:525\u201332.","journal-title":"Circ Res"},{"key":"1445_CR74","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/ATVBAHA.122.318048","volume":"42","author":"A Zietzer","year":"2022","unstructured":"Zietzer A, D\u00fcsing P, Reese L, Nickenig G, Jansen F. Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential. Arterioscler Thromb Vasc Biol. 2022;42:1220\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR75","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41586-025-08792-8","volume":"641","author":"S Zhang","year":"2025","unstructured":"Zhang S, Lin H, Wang J, Rui J, Wang T, Cai Z, et al. Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis. Nature. 2025;641:476\u201385.","journal-title":"Nature"},{"key":"1445_CR76","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1074\/jbc.273.5.2738","volume":"273","author":"SL Schissel","year":"1998","unstructured":"Schissel SL, Jiang X, Tweedie-Hardman J, Jeong T, Camejo EH, Najib J, Rapp JH, Williams KJ, Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem. 1998;273:2738\u201346.","journal-title":"J Biol Chem"},{"key":"1445_CR77","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0022-2275(20)41992-3","volume":"32","author":"JR Guyton","year":"1991","unstructured":"Guyton JR, Klemp KF, Mims MP. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. J Lipid Res. 1991;32:953\u201362.","journal-title":"J Lipid Res"},{"key":"1445_CR78","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/eurheartj\/ehy319","volume":"39","author":"M Ruuth","year":"2018","unstructured":"Ruuth M, Nguyen SD, Vihervaara T, Hilvo M, Laajala TD, Kondadi PK, et al. Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths. Eur Heart J. 2018;39:2562\u201373.","journal-title":"Eur Heart J"},{"key":"1445_CR79","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/HYPERTENSIONAHA.119.14507","volume":"75","author":"A Cantalupo","year":"2020","unstructured":"Cantalupo A, Sasset L, Gargiulo A, Rubinelli L, Del Gaudio I, Benvenuto D, Wadsack C, Jiang XC, Bucci MR, Di Lorenzo A. Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide. Hypertension. 2020;75:1279\u201388.","journal-title":"Hypertension"},{"key":"1445_CR80","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.biocel.2011.12.019","volume":"44","author":"D Hartmann","year":"2012","unstructured":"Hartmann D, Lucks J, Fuchs S, Schiffmann S, Schreiber Y, Ferreir\u00f3s N, Merkens J, Marschalek R, Geisslinger G, Gr\u00f6sch S. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int J Biochem Cell Biol. 2012;44:620\u20138.","journal-title":"Int J Biochem Cell Biol"},{"key":"1445_CR81","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1096\/fj.201700300R","volume":"32","author":"BA Law","year":"2018","unstructured":"Law BA, Liao X, Moore KS, Southard A, Roddy P, Ji R, Szulc Z, Bielawska A, Schulze PC, Cowart LA. Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes. FASEB J. 2018;32:1403\u201316.","journal-title":"FASEB J"},{"key":"1445_CR82","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/BJ20111626","volume":"441","author":"TD Mullen","year":"2012","unstructured":"Mullen TD, Hannun YA, Obeid LM. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem J. 2012;441:789\u2013802.","journal-title":"Biochem J"},{"key":"1445_CR83","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1074\/jbc.M110.164392","volume":"286","author":"SA Novgorodov","year":"2011","unstructured":"Novgorodov SA, Chudakova DA, Wheeler BW, Bielawski J, Kindy MS, Obeid LM, Gudz TI. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2\u2009+\u2009loading capacity and promotes apoptosis. J Biol Chem. 2011;286:4644\u201358.","journal-title":"J Biol Chem"},{"key":"1445_CR84","first-page":"3344","volume":"42","author":"P Zhang","year":"2018","unstructured":"Zhang P, Hua L, Hou H, Du X, He Z, Liu M, Hu X, Yan N. Sphingomyelin synthase 2 promotes H2O2-induced endothelial dysfunction by activating the Wnt\/\u03b2-catenin signaling pathway. Int J Mol Med. 2018;42:3344\u201354.","journal-title":"Int J Mol Med"},{"key":"1445_CR85","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/ATVBAHA.108.168682","volume":"28","author":"TK Hailemariam","year":"2008","unstructured":"Hailemariam TK, Huan C, Liu J, Li Z, Roman C, Kalbfeisch M, Bui HH, Peake DA, Kuo MS, Cao G, Wadgaonkar R, Jiang XC. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation. Arterioscler Thromb Vasc Biol. 2008;28:1519\u201326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR86","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","volume":"32","author":"Z Li","year":"2012","unstructured":"Li Z, Fan Y, Liu J, Li Y, Huan C, Bui HH, Kuo MS, Park TS, Cao G, Jiang XC. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2012;32:1577\u201384.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122861","author":"L Hua","year":"2019","unstructured":"Hua L, Wu N, Zhao R, He X, Liu Q, Li X, et al. Sphingomyelin synthase 2 promotes endothelial dysfunction by inducing endoplasmic reticulum stress. Int J Mol Sci. 2019;20:2861. https:\/\/doi.org\/10.3390\/ijms20122861.","journal-title":"Int J Mol Sci"},{"key":"1445_CR88","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmet.2024.10.016","volume":"37","author":"JM Gengatharan","year":"2025","unstructured":"Gengatharan JM, Handzlik MK, Chih ZY, Ruchhoeft ML, Secrest P, Ashley EL, Green CR, Wallace M, Gordts PLSM, Metallo CM. Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis. Cell Metab. 2025;37:274\u2013e290279.","journal-title":"Cell Metab"},{"key":"1445_CR89","doi-asserted-by":"publisher","first-page":"29127","DOI":"10.1074\/jbc.273.44.29127","volume":"273","author":"K O\u00f6rni","year":"1998","unstructured":"O\u00f6rni K, Hakala JK, Annila A, Ala-Korpela M, Kovanen PT. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J Biol Chem. 1998;273:29127\u201334.","journal-title":"J Biol Chem"},{"key":"1445_CR90","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1194\/jlr.M600040-JLR200","volume":"47","author":"J Dong","year":"2006","unstructured":"Dong J, Liu J, Lou B, Li Z, Ye X, Wu M, Jiang XC. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice. J Lipid Res. 2006;47:1307\u201314.","journal-title":"J Lipid Res"},{"key":"1445_CR91","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/ATVBAHA.110.213363","volume":"30","author":"Y Fan","year":"2010","unstructured":"Fan Y, Shi F, Liu J, Dong J, Bui HH, Peake DA, Kuo MS, Cao G, Jiang XC. Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:2114\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR92","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCRESAHA.109.194613","volume":"105","author":"J Liu","year":"2009","unstructured":"Liu J, Huan C, Chakraborty M, Zhang H, Lu D, Kuo MS, Cao G, Jiang XC. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res. 2009;105:295\u2013303.","journal-title":"Circ Res"},{"key":"1445_CR93","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.2174\/1381612811319330005","volume":"19","author":"HS Kruth","year":"2013","unstructured":"Kruth HS. Fluid-phase pinocytosis of LDL by macrophages: a novel target to reduce macrophage cholesterol accumulation in atherosclerotic lesions. Curr Pharm Des. 2013;19:5865\u201372.","journal-title":"Curr Pharm Des"},{"key":"1445_CR94","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1161\/ATVBAHA.110.210849","volume":"30","author":"JJ Anzinger","year":"2010","unstructured":"Anzinger JJ, Chang J, Xu Q, Buono C, Li Y, Leyva FJ, Park BC, Greene LE, Kruth HS. Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis. Arterioscler Thromb Vasc Biol. 2010;30:2022\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132058","author":"G Bravo","year":"2022","unstructured":"Bravo G, Cede\u00f1o RR, Casadevall MP, Rami\u00f3-Torrent\u00e0 L. Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11132058.","journal-title":"Cells"},{"key":"1445_CR96","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1194\/jlr.R046300","volume":"55","author":"VA Blaho","year":"2014","unstructured":"Blaho VA, Hla T. An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res. 2014;55:1596\u2013608.","journal-title":"J Lipid Res"},{"key":"1445_CR97","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5551\/jat.RV17010","volume":"25","author":"M Kurano","year":"2018","unstructured":"Kurano M, Yatomi Y. Sphingosine 1-Phosphate and Atherosclerosis. J Atheroscler Thromb. 2018;25:16\u201326.","journal-title":"J Atheroscler Thromb"},{"key":"1445_CR98","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","volume":"102","author":"K Venkataraman","year":"2008","unstructured":"Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, Parikh NS, Habrukowich C, Hla T. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circul Res. 2008;102:669\u201376.","journal-title":"Circul Res"},{"key":"1445_CR99","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.1139221","volume":"316","author":"R Pappu","year":"2007","unstructured":"Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, Coughlin SR. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science. 2007;316:295\u20138.","journal-title":"Science"},{"key":"1445_CR100","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature24053","volume":"550","author":"TM Vu","year":"2017","unstructured":"Vu TM, Ishizu AN, Foo JC, Toh XR, Zhang F, Whee DM, Torta F, Cazenave-Gassiot A, Matsumura T, Kim S, Toh SES, Suda T, Silver DL, Wenk MR, Nguyen LN. Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets. Nature. 2017;550:524\u20138.","journal-title":"Nature"},{"key":"1445_CR101","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1167449","volume":"323","author":"A Kawahara","year":"2009","unstructured":"Kawahara A, Nishi T, Hisano Y, Fukui H, Yamaguchi A, Mochizuki N. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science. 2009;323:524\u20137.","journal-title":"Science"},{"key":"1445_CR102","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1042\/bj3520809","volume":"3","author":"N Murata","year":"2000","unstructured":"Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M, Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352 Pt. 2000;3:809\u201315.","journal-title":"Biochem J 352 Pt"},{"key":"1445_CR103","doi-asserted-by":"publisher","first-page":"107837","DOI":"10.1016\/j.jbc.2024.107837","volume":"300","author":"Q Jones","year":"2024","unstructured":"Jones Q, Zheng J, Li Z, He M, Li X, Dai K, Worgall TS, Yu Y, Jiang XC. Effect of phospholipid transfer protein on plasma sphingosine-1-phosphate. J Biol Chem. 2024;300:107837.","journal-title":"J Biol Chem"},{"key":"1445_CR104","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1194\/jlr.RA119000277","volume":"60","author":"H Obinata","year":"2019","unstructured":"Obinata H, Kuo A, Wada Y, Swendeman S, Liu CH, Blaho VA, Nagumo R, Satoh K, Izumi T, Hla T. Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. J Lipid Res. 2019;60:1912\u201321.","journal-title":"J Lipid Res"},{"key":"1445_CR105","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/ATVBAHA.116.308435","volume":"37","author":"M Ruiz","year":"2017","unstructured":"Ruiz M, Frej C, Holm\u00e9r A, Guo LJ, Tran S, Dahlb\u00e4ck B. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Arterioscler Thromb Vasc Biol. 2017;37:118\u201329.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR106","doi-asserted-by":"publisher","first-page":"12420","DOI":"10.1074\/jbc.M008375200","volume":"276","author":"J Igarashi","year":"2001","unstructured":"Igarashi J, Bernier SG, Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem. 2001;276:12420\u20136.","journal-title":"J Biol Chem"},{"key":"1445_CR107","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.117.09088","volume":"70","author":"A Cantalupo","year":"2017","unstructured":"Cantalupo A, Gargiulo A, Dautaj E, Liu C, Zhang Y, Hla T, Di Lorenzo A. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure. Hypertension. 2017;70:426\u201334.","journal-title":"Hypertension"},{"key":"1445_CR108","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2021.1959243","volume":"9","author":"CM Warboys","year":"2021","unstructured":"Warboys CM, Weinberg PD. S1P in the development of atherosclerosis: roles of hemodynamic wall shear stress and endothelial permeability. Tissue Barriers. 2021;9:1959243.","journal-title":"Tissue Barriers"},{"key":"1445_CR109","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1515\/hsz-2014-0305","volume":"396","author":"PL Jernigan","year":"2015","unstructured":"Jernigan PL, Makley AT, Hoehn RS, Edwards MJ, Pritts TA. The role of sphingolipids in endothelial barrier function. Biol Chem. 2015;396:681\u201391.","journal-title":"Biol Chem"},{"key":"1445_CR110","doi-asserted-by":"crossref","unstructured":"Jujic A, Matthes F, Vanherle L, Petzka H, Orho-Melander M, Nilsson PM, Magnusson M, Meissner A. Plasma S1P (Sphingosine-1-Phosphate) Links to Hypertension and Biomarkers of Inflammation and Cardiovascular Disease: Findings From a Translational Investigation. Volume 78. Hypertension; 2021. pp. 195\u2013209.","DOI":"10.1161\/HYPERTENSIONAHA.120.17379"},{"key":"1445_CR111","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/CIRCRESAHA.123.323826","volume":"134","author":"OL Manzo","year":"2024","unstructured":"Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, et al. Rewiring endothelial sphingolipid metabolism to favor S1P over ceramide protects from coronary atherosclerosis. Circ Res. 2024;134:990\u20131005.","journal-title":"Circ Res"},{"key":"1445_CR112","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1182\/blood-2015-08-662635","volume":"127","author":"M Flori","year":"2016","unstructured":"Flori M, Schmid CA, Sumrall ET, Tzankov A, Law CW, Robinson MD, M\u00fcller A. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling. Blood. 2016;127:1438\u201348.","journal-title":"Blood"},{"key":"1445_CR113","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12967-017-1305-6","volume":"15","author":"CR Justus","year":"2017","unstructured":"Justus CR, Sanderlin EJ, Dong L, Sun T, Chi JT, Lertpiriyapong K, Yang LV. Contextual tumor suppressor function of T cell death-associated gene 8 (TDAG8) in hematological malignancies. J Transl Med. 2017;15:204.","journal-title":"J Transl Med"},{"key":"1445_CR114","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1212\/WNL.0000000000207779","volume":"101","author":"E Benarroch","year":"2023","unstructured":"Benarroch E. What Is the Role of the Rho-ROCK Pathway in Neurologic Disorders? Neurology. 2023;101:536\u201343.","journal-title":"Neurology"},{"key":"1445_CR115","doi-asserted-by":"publisher","first-page":"809425","DOI":"10.3389\/fcell.2022.809425","volume":"10","author":"P Guo","year":"2022","unstructured":"Guo P, Tai Y, Wang M, Sun H, Zhang L, Wei W, Xiang YK, Wang Q. G\u03b1 Front Cell Dev Biol. 2022;10:809425.","journal-title":"G\u03b1 Front Cell Dev Biol"},{"key":"1445_CR116","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1161\/ATVBAHA.110.213496","volume":"31","author":"A Skoura","year":"2011","unstructured":"Skoura A, Michaud J, Im DS, Thangada S, Xiong Y, Smith JD, Hla T. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31:81\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR117","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCRESAHA.110.235028","volume":"108","author":"P Keul","year":"2011","unstructured":"Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Gr\u00e4ler M, Heusch G, Levkau B. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte\/macrophages in inflammation and atherosclerosis. Circ Res. 2011;108:314\u201323.","journal-title":"Circ Res"},{"key":"1445_CR118","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/01.ATV.0000254679.42583.88","volume":"27","author":"P Keul","year":"2007","unstructured":"Keul P, T\u00f6lle M, Lucke S, von Wnuck Lipinski K, Heusch G, Schuchardt M, van der Giet M, Levkau B. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:607\u201313.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR119","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2362.2007.01776.x","volume":"37","author":"M T\u00f6lle","year":"2007","unstructured":"T\u00f6lle M, Levkau B, Kleuser B, van der Giet M. Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds. Eur J Clin Invest. 2007;37:171\u20139.","journal-title":"Eur J Clin Invest"},{"key":"1445_CR120","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/STROKEAHA.109.568899","volume":"41","author":"Y Hasegawa","year":"2010","unstructured":"Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke. 2010;41:368\u201374.","journal-title":"Stroke"},{"key":"1445_CR121","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1084\/jem.20091343","volume":"207","author":"S Thangada","year":"2010","unstructured":"Thangada S, Khanna KM, Blaho VA, Oo ML, Im DS, Guo C, Lefrancois L, Hla T. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. J Exp Med. 2010;207:1475\u201383.","journal-title":"J Exp Med"},{"key":"1445_CR122","doi-asserted-by":"crossref","unstructured":"Tachibana K, Kusumoto K, Ogawa M, Ando H, Shimizu T, Ishima Y, Ishida T, Okuhira K. FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages. Int J Mol Sci, 23 (2022).","DOI":"10.3390\/ijms232314617"},{"key":"1445_CR123","doi-asserted-by":"crossref","unstructured":"Ryckman AE, Brockhausen I, Walia JS. Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders. Int J Mol Sci, 21 (2020).","DOI":"10.3390\/ijms21186881"},{"key":"1445_CR124","doi-asserted-by":"crossref","unstructured":"Huang S, Abutaleb K, Mishra S. Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models, Biomolecules, 14 (2024).","DOI":"10.20944\/preprints202409.0649.v1"},{"key":"1445_CR125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/glycob\/7.1.57","volume":"7","author":"SB Chatterjee","year":"1997","unstructured":"Chatterjee SB, Dey S, Shi WY, Thomas K, Hutchins GM. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology. 1997;7:57\u201365.","journal-title":"Glycobiology"},{"key":"1445_CR126","first-page":"BR270","volume":"15","author":"J Bismuth","year":"2009","unstructured":"Bismuth J, Chai H, Lin PH, Yao Q, Chen C. Lactosylceramide causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Med Sci Monit. 2009;15:BR270\u2013274.","journal-title":"Med Sci Monit"},{"key":"1445_CR127","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/01.RES.82.5.540","volume":"82","author":"T Arai","year":"1998","unstructured":"Arai T, Bhunia AK, Chatterjee S, Bulkley GB. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ Res. 1998;82:540\u20137.","journal-title":"Circ Res"},{"key":"1445_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911948","author":"L Peters","year":"2022","unstructured":"Peters L, Kuebler WM, Simmons S. Sphingolipids in atherosclerosis: chimeras in structure and function. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231911948.","journal-title":"Int J Mol Sci"},{"key":"1445_CR129","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1074\/jbc.271.18.10660","volume":"271","author":"AK Bhunia","year":"1996","unstructured":"Bhunia AK, Han H, Snowden A, Chatterjee S. Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells. J Biol Chem. 1996;271:10660\u20136.","journal-title":"J Biol Chem"},{"key":"1445_CR130","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/ol.2016.5110","volume":"12","author":"L Li","year":"2016","unstructured":"Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12:3045\u201350.","journal-title":"Oncol Lett"},{"key":"1445_CR131","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/CS20191028","volume":"134","author":"Z Yu","year":"2020","unstructured":"Yu Z, Peng Q, Li S, Hao H, Deng J, Meng L, Shen Z, Yu W, Nan D, Bai Y, Huang Y. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-\/- mice via reducing lipid uptake and vascular inflammation. Clin Sci (Lond). 2020;134:439\u201358.","journal-title":"Clin Sci (Lond)"},{"key":"1445_CR132","doi-asserted-by":"publisher","first-page":"13600","DOI":"10.1038\/s41598-018-31926-0","volume":"8","author":"E Mobarak","year":"2018","unstructured":"Mobarak E, H\u00e5versen L, Manna M, Rutberg M, Levin M, Perkins R, Rog T, Vattulainen I, Bor\u00e9n J. Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS\/TLR4 complex in silico. Sci Rep. 2018;8:13600.","journal-title":"Sci Rep"},{"key":"1445_CR133","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbalip.2014.12.004","volume":"1851","author":"S Nikolaeva","year":"2015","unstructured":"Nikolaeva S, Bayunova L, Sokolova T, Vlasova Y, Bachteeva V, Avrova N, Parnova R. GM1 and GD1a gangliosides modulate toxic and inflammatory effects of E. coli lipopolysaccharide by preventing TLR4 translocation into lipid rafts. Biochim Biophys Acta. 2015;1851:239\u201347.","journal-title":"Biochim Biophys Acta"},{"key":"1445_CR134","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.nutres.2015.01.001","volume":"35","author":"M Yeom","year":"2015","unstructured":"Yeom M, Park J, Lim C, Sur B, Lee B, Han JJ, et al. Glucosylceramide attenuates the inflammatory mediator expression in lipopolysaccharide-stimulated RAW264.7 cells. Nutr Res. 2015;35:241\u201350.","journal-title":"Nutr Res"},{"key":"1445_CR135","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/ATVBAHA.109.201673","volume":"30","author":"F Bietrix","year":"2010","unstructured":"Bietrix F, Lombardo E, van Roomen CP, Ottenhoff R, Vos M, Rensen PC, Verhoeven AJ, Aerts JM, Groen AK. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-\/- mice. Arterioscler Thromb Vasc Biol. 2010;30:931\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1445_CR136","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0021-9150(92)90253-D","volume":"93","author":"DN Mukhin","year":"1992","unstructured":"Mukhin DN, Prokazova NV. Neutral glycosphingolipid content and composition of cells from normal and atherosclerotic human aorta. Atherosclerosis. 1992;93:173\u20137.","journal-title":"Atherosclerosis"},{"key":"1445_CR137","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.aav3722","volume":"365","author":"B Chaurasia","year":"2019","unstructured":"Chaurasia B, Tippetts TS, Mayoral Monibas R, Liu J, Li Y, Wang L, Wilkerson JL, Sweeney CR, Pereira RF, Sumida DH, Maschek JA, Cox JE, Kaddai V, Lancaster GI, Siddique MM, Poss A, Pearson M, Satapati S, Zhou H, McLaren DG, Previs SF, Chen Y, Qian Y, Petrov A, Wu M, Shen X, Yao J, Nunes CN, Howard AD, Wang L, Erion MD, Rutter J, Holland WL, Kelley DE, Summers SA. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science. 2019;365:386\u201392.","journal-title":"Science"},{"key":"1445_CR138","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00125-013-3123-6","volume":"57","author":"S Fayyaz","year":"2014","unstructured":"Fayyaz S, Henkel J, Japtok L, Kramer S, Damm G, Seehofer D, Puschel GP, Kleuser B. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype. Diabetologia. 2014;57:373\u201382.","journal-title":"Diabetologia"},{"key":"1445_CR139","doi-asserted-by":"publisher","first-page":"22193","DOI":"10.1074\/jbc.M113.477786","volume":"288","author":"JS Ross","year":"2013","unstructured":"Ross JS, Hu W, Rosen B, Snider AJ, Obeid LM, Cowart LA. Sphingosine kinase 1 is regulated by peroxisome proliferator-activated receptor alpha in response to free fatty acids and is essential for skeletal muscle interleukin-6 production and signaling in diet-induced obesity. J Biol Chem. 2013;288:22193\u2013206.","journal-title":"J Biol Chem"},{"key":"1445_CR140","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000362990","volume":"34","author":"S Fayyaz","year":"2014","unstructured":"Fayyaz S, Japtok L, Kleuser B. Divergent role of sphingosine 1-phosphate on insulin resistance. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2014;34:134\u201347.","journal-title":"Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol"},{"key":"1445_CR141","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2337\/db06-1619","volume":"56","author":"JM Aerts","year":"2007","unstructured":"Aerts JM, Ottenhoff R, Powlson AS, Grefhorst A, van Eijk M, Dubbelhuis PF, Aten J, Kuipers F, Serlie MJ, Wennekes T, Sethi JK, O\u2019Rahilly S, Overkleeft HS. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes. 2007;56:1341\u20139.","journal-title":"Diabetes"},{"key":"1445_CR142","doi-asserted-by":"crossref","unstructured":"Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A, Kono M, Tsuji S, Daniotti J.L., Werth N, Sandhoff R, Sandhoff K, Proia R.L. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA. 2003;100:3445\u20139.","DOI":"10.1073\/pnas.0635898100"},{"key":"1445_CR143","doi-asserted-by":"publisher","first-page":"13678","DOI":"10.1073\/pnas.0703650104","volume":"104","author":"K Kabayama","year":"2007","unstructured":"Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S, Kinjo M, Igarashi Y, Inokuchi J. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA. 2007;104:13678\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1445_CR144","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1128\/MCB.05893-11","volume":"31","author":"Z Li","year":"2011","unstructured":"Li Z, Zhang H, Liu J, Liang CP, Li Y, Li Y, Teitelman G, Beyer T, Bui HH, Peake DA, Zhang Y, Sanders PE, Kuo MS, Park TS, Cao G, Jiang XC. Reducing plasma membrane sphingomyelin increases insulin sensitivity. Mol Cell Biol. 2011;31:4205\u201318.","journal-title":"Mol Cell Biol"},{"key":"1445_CR145","doi-asserted-by":"publisher","first-page":"28544","DOI":"10.1074\/jbc.M111.255646","volume":"286","author":"S Mitsutake","year":"2011","unstructured":"Mitsutake S, Zama K, Yokota H, Yoshida T, Tanaka M, Mitsui M, Ikawa M, Okabe M, Tanaka Y, Yamashita T, Takemoto H, Okazaki T, Watanabe K, Igarashi Y. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes. J Biol Chem. 2011;286:28544\u201355.","journal-title":"J Biol Chem"},{"key":"1445_CR146","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bbalip.2016.04.019","volume":"1861","author":"M Sugimoto","year":"2016","unstructured":"Sugimoto M, Shimizu Y, Zhao S, Ukon N, Nishijima K, Wakabayashi M, Yoshioka T, Higashino K, Numata Y, Okuda T, Tamaki N, Hanamatsu H, Igarashi Y, Kuge Y. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice. Biochim Biophys Acta. 2016;1861:688\u2013702.","journal-title":"Biochim Biophys Acta"},{"key":"1445_CR147","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","volume":"5","author":"WL Holland","year":"2007","unstructured":"Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 2007;5:167\u201379.","journal-title":"Cell Metab"},{"key":"1445_CR148","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12944-019-1118-0","volume":"18","author":"RX Yang","year":"2019","unstructured":"Yang RX, Pan Q, Liu XL, Zhou D, Xin FZ, Zhao ZH, Zhang RN, Zeng J, Qiao L, Hu CX, Xu GW, Fan JG. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Lipids Health Dis. 2019;18:179.","journal-title":"Lipids Health Dis"},{"key":"1445_CR149","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2013.01.041","volume":"228","author":"MJ Dekker","year":"2013","unstructured":"Dekker MJ, Baker C, Naples M, Samsoondar J, Zhang R, Qiu W, Sacco J, Adeli K. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction. Atherosclerosis. 2013;228:98\u2013109.","journal-title":"Atherosclerosis"},{"key":"1445_CR150","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1161\/01.CIR.0000148370.60535.22","volume":"110","author":"TS Park","year":"2004","unstructured":"Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, Kindt EK, Homan R, Karathanasis SK, Rekhter MD. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2004;110:3465\u201371.","journal-title":"Circulation"},{"key":"1445_CR151","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI60415","volume":"123","author":"M Chakraborty","year":"2013","unstructured":"Chakraborty M, Lou C, Huan C, Kuo MS, Park TS, Cao G, Jiang XC. Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis. J Clin Invest. 2013;123:1784\u201397.","journal-title":"J Clin Invest"},{"key":"1445_CR152","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tox.2004.04.019","volume":"201","author":"VJ Johnson","year":"2004","unstructured":"Johnson VJ, He Q, Osuchowski MF, Sharma RP. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. Toxicology. 2004;201:67\u201375.","journal-title":"Toxicology"},{"key":"1445_CR153","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1177391X0700100002","volume":"1","author":"K Adachi","year":"2007","unstructured":"Adachi K, Chiba K. FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology. Perspect Medicin Chem. 2007;1:11\u201323.","journal-title":"Perspect Medicin Chem"},{"key":"1445_CR154","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrneurol.2010.76","volume":"6","author":"O Aktas","year":"2010","unstructured":"Aktas O, Kury P, Kieseier B, Hartung HP. Fingolimod is a potential novel therapy for multiple sclerosis. Nat Rev Neurol. 2010;6:373\u201382.","journal-title":"Nat Rev Neurol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-026-01445-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-026-01445-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:02:09Z","timestamp":1786010529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-026-01445-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1007\/s11883-026-01445-9","relation":{},"ISSN":["1534-6242"],"issn-type":[{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All studies with human or animal subjects are published and followed ethical standards.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}